Literature DB >> 27560948

Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015.

Alexis B Peterson, R Matthew Gladden, Chris Delcher, Erica Spies, Amanda Garcia-Williams, Yanning Wang, John Halpin, Jon Zibbell, Carolyn Lullo McCarty, Jolene DeFiore-Hyrmer, Mary DiOrio, Bruce A Goldberger.   

Abstract

In March and October 2015, the Drug Enforcement Administration (DEA) and CDC issued nationwide alerts identifying fentanyl, particularly illicitly manufactured fentanyl (IMF), as a threat to public health and safety (1,2). IMF is pharmacologically similar to pharmaceutical fentanyl (PF), but is unlawfully produced in clandestine laboratories, obtained via illicit drug markets, and includes fentanyl analogs. Fentanyl is a synthetic opioid 50-100 times more potent than morphine and approved for the management of surgical/postoperative pain, severe chronic pain, and breakthrough cancer pain.* DEA's National Forensic Laboratory Information System (NFLIS) collects drug identification results from drug cases analyzed by federal, state, and local forensic laboratories throughout the United States.(†) In 2014, 80% of fentanyl submissions (i.e., drug products obtained by law enforcement that tested positive for fentanyl) in NFLIS were identified from 10 states, including Florida and Ohio (2), and seven of these 10 states reported sharp increases in fentanyl-related overdose deaths (fentanyl deaths) (3). This report presents findings of increased fentanyl deaths during 2013-2015 from investigations conducted by the University of Florida and the Ohio Department of Public Health, in collaboration with CDC. Analyses examined the association between trends in fentanyl-related law enforcement submissions and fentanyl deaths and describes groups at risk for fentanyl death using medical examiner and coroner reports. The marked increases in fentanyl death in Florida and Ohio during 2013-2015 were closely associated with parallel increases in fentanyl submissions, with the largest impact on persons who use heroin, consistent with reports that IMF is commonly mixed with or sold as heroin (1,4). In Ohio, circumstances associated with fentanyl deaths included a current diagnosed mental health disorder(§) and recent release from an institution such as a jail, rehabilitation facility, or hospital.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27560948     DOI: 10.15585/mmwr.mm6533a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  65 in total

1.  Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances.

Authors:  Denise B Kandel; Mei-Chen Hu; Pamela Griesler; Melanie Wall
Journal:  Drug Alcohol Depend       Date:  2017-07-04       Impact factor: 4.492

2.  Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Authors:  Ofer Amram; Eugenia Socías; Ekaterina Nosova; Thomas Kerr; Evan Wood; Kora DeBeck; Kanna Hayashi; Nadia Fairbairn; Julio Montaner; M J Milloy
Journal:  Spat Spatiotemporal Epidemiol       Date:  2019-07-04

3.  Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.

Authors:  Yanjia Cao; Kathleen Stewart; Eric Wish; Eleanor Artigiani; Marcella H Sorg
Journal:  J Subst Abuse Treat       Date:  2019-04-05

4.  Public Health Impact: How Medicolegal Death Investigation Data Help the Living.

Authors:  Paula A Brown; Margaret Warner
Journal:  Acad Forensic Pathol       Date:  2017-12-01

5.  Emerging threats in addiction: will novel psychoactive substances contribute to exacerbating the ongoing drug overdose epidemic?

Authors:  F Scott Hall; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2019-03       Impact factor: 4.530

Review 6.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

7.  Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.

Authors:  Hawre Jalal; Jeanine M Buchanich; Mark S Roberts; Lauren C Balmert; Kun Zhang; Donald S Burke
Journal:  Science       Date:  2018-09-21       Impact factor: 47.728

8.  Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD.

Authors:  Sarah G Mars; Jeff Ondocsin; Daniel Ciccarone
Journal:  J Psychoactive Drugs       Date:  2017-12-06

9.  Estimating the Risk of Exposure to Fentanyl in New York City: Testing Drug Residue in Used Syringes.

Authors:  Jaclyn Blachman-Forshay; Michelle L Nolan; Jonathan M McAteer; Denise Paone
Journal:  Am J Public Health       Date:  2018-10-25       Impact factor: 9.308

Review 10.  Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors:  Evan Stuart Bradley; David Liss; Stephanie Pepper Carreiro; David Eric Brush; Kavita Babu
Journal:  Clin Toxicol (Phila)       Date:  2019-03-04       Impact factor: 4.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.